Ekpunobi Resigns as Neimeth Pharmaceuticals CEO

September 28, 2017
Neimeth Pharmaceuticals

By Modupe Gbadeyanka

Mrs Ebere lgboko Ekpunobi has resigned as the Managing Director/CEO of Neimeth International Pharmaceuticals Plc.

This information was revealed by the firm yesterday in a notice to the Nigerian Stock Exchange (NSE) and signed by its scribe, Mrs F. I. Onyenekwe.

It was disclosed that Mrs Ekpunobi’s resignation has been accepted by the Board of Directors of Neimeth International Pharmaceuticals Plc.

It was explained that Mrs Ekpunobi, who joined Neimeth International Pharmaceuticals Plc in November 2015 as Acting Managing Director and was confirmed to the position in March 2016, suffered a sporting accident on May 18, 2017, and had to travel overseas for medication which is still on-going and has necessitated her resignation on September 11, 2017.

“The Board wishes her God’s complete healing and success in her future endeavours,” the statement said.

In view of this development, the board has announced the appointment of Mr Chris Mmeje as the Acting Managing Director/CEO of the pharmaceutical firm with immediate effect.

Mr Mmeje has been the Finance Director of the company since 2008 and prior to that, he had distinguished career in the banking industry that spanned over 25 years. He will oversee the affairs of the company until the emergence of a substantive Managing Director.

Modupe Gbadeyanka

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

Leave a Reply

WAEC Boosts Credibility of NNPC Annual Quiz Competition
Previous Story

WAEC Boosts Credibility of NNPC Annual Quiz Competition

Nigeria Raises N243.8b from N135b Bond Exercise
Next Story

Nigeria Raises N243.8b from N135b Bond Exercise

Latest from Health

Don't Miss